Seemed fine to me, I also didn't see a problem with the senior management change either. They're repositioning themselves for future growth. It'll bounce back.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025